Cargando…

Vaccine Response in the Immunocompromised Patient with Focus on Cellular Immunity

Detalles Bibliográficos
Autores principales:	Bahrs, Christina, Harrison, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230619/ https://www.ncbi.nlm.nih.gov/pubmed/35746489 http://dx.doi.org/10.3390/vaccines10060882

Ejemplares similares

Humoral and cellular response to the COVID-19 vaccine in immunocompromised children
por: Morgans, Heather A., et al.
Publicado: (2022)

Microneedle patch for immunization of immunocompromised hosts
por: Rouphael, Nadine G., et al.
Publicado: (2017)

Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals
por: Paramithiotis, Eustache, et al.
Publicado: (2022)

Immunologic Monitoring of Cellular Immune Responses in Cancer Vaccine Therapy
por: Whiteside, Theresa L., et al.
Publicado: (2011)

Differential cellular and humoral immune responses in immunocompromised individuals following multiple SARS-CoV-2 vaccinations
por: Meredith, Rhys T., et al.
Publicado: (2023)

Monitoring Cellular Immune Responses after Consumption of Selected Probiotics in Immunocompromised Mice
por: Kang, Seok-Jin, et al.
Publicado: (2022)

Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
por: Oyaert, Matthijs, et al.
Publicado: (2022)

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
por: Boekel, Laura
Publicado: (2022)

Inadequate Antibody Response to Rabies Vaccine in Immunocompromised Patient
por: Kopel, Eran, et al.
Publicado: (2012)

Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment
por: Thümmler, Laura, et al.
Publicado: (2022)

In focus in Vienna: Microscopy and cellular organelles
por: Stöger-Pollach, Michael
Publicado: (2022)

The Willingness toward Vaccination: A Focus on Non-Mandatory Vaccinations
por: Capodici, Angelo, et al.
Publicado: (2023)

Immunocompromised Patients with Acute Respiratory Failure: “Don’t Wait to Intubate”?
por: Pickkers, Peter, et al.
Publicado: (2021)

Vaccination of Immunocompromised Cats
por: Hartmann, Katrin, et al.
Publicado: (2022)

Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview
por: Dagnew, Alemnew F., et al.
Publicado: (2021)

Adaptive immune response to BNT162b2 mRNA vaccine in immunocompromised adolescent patients
por: Bader, Guy, et al.
Publicado: (2023)

COVID-19 vaccination in immunocompromised patients
por: Sonani, Bhavin, et al.
Publicado: (2021)

Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after Vaccination
por: Harrison, Nicole, et al.
Publicado: (2021)

Immune Response to COVID-19 and mRNA Vaccination in Immunocompromised Individuals: A Narrative Review
por: Napuri, Norka I., et al.
Publicado: (2022)

WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
por: Franchini, Massimo, et al.
Publicado: (2023)

HPV vaccination of immunocompromised hosts
por: Garland, S.M., et al.
Publicado: (2017)

Administration of COVID-19 vaccines in immunocompromised patients
por: Negahdaripour, Manica, et al.
Publicado: (2021)

Vaccines and therapeutics for immunocompromised patients with COVID-19
por: Shoham, Shmuel, et al.
Publicado: (2023)

Aging alters immune responses to vaccines
por: Connors, Jennifer, et al.
Publicado: (2021)

Immune Response of the Host and Vaccine Development
por: Długosz, Ewa, et al.
Publicado: (2023)

Immunocompromised hosts: Infections and biomarkers
por: Kulkarni, Atul P.
Publicado: (2013)

Preservation of the Innate Immune Response to Clostridioides difficile Infection in Hospitalized Immunocompromised Patients
por: Banegas, Marcela, et al.
Publicado: (2023)

Metabolic Inflammation and Cellular Immunity
por: Sindhu, Sardar, et al.
Publicado: (2023)

HPV Carcinomas in Immunocompromised Patients
por: Reusser, Nicole M., et al.
Publicado: (2015)

Immune Response to Hepatitis B Vaccine in Patients with Chronic Kidney Disease
por: Einollahi, Behzad
Publicado: (2011)

Immune response to vaccines in children with celiac disease
por: Anania, Caterina, et al.
Publicado: (2017)

Acute and latent viral infections in immunocompromised patients: a tale of brave battles and menacing foes
por: Spallone, Amy, et al.
Publicado: (2022)

Cellular Immune Response after Vaccination in Patients with Cancer—Review on Past and Present Experiences
por: Rüthrich, Maria Madeleine, et al.
Publicado: (2022)

Pneumococcal Vaccination in Immunocompromised Hosts: An Update
por: Froneman, Claire, et al.
Publicado: (2021)

COVID-19 vaccines for high risk and immunocompromised patients
por: Pavia, Charles S., et al.
Publicado: (2022)

Safety and immunogenicity of COVID-19 vaccination in immunocompromised patients
por: Song, Jin-Wen, et al.
Publicado: (2022)

Malaria vaccine deployment in Africa: focus on Ghana
por: Asante, Kwaku Poku, et al.
Publicado: (2019)

Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings
por: Ferreira, Victor H., et al.
Publicado: (2022)

Immunocompromised Patients
por: Humphreys, Hilary, et al.
Publicado: (2012)

Neuraminidase-Inhibiting Antibody Response to H5N1 Virus Vaccination in Chronically Ill and Immunocompromised Patients
por: Fritz, Richard, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m940vo6smm9gf2hph58kdh38ir